Naltrexone Injection [Vivitrol]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
IntroductionAn extended-release injectable naltrexone suspension (Vivitrol®) was approved in USA in 2010 for the prevention of…
“Addiction” is a complex neurobiological process of hedonic dysregulation. It is characterized in humans by compulsive use of…
More than 17 million persons aged 12 or older in the United States in 2013 (6.6 percent of the population) had alcohol use…
Background In 2010, the FDA approved the use of extended-release injectable naltrexone (Vivitrol©) for the treatment of opioid…